Eukles Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Eukles Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.2K	Hold	162	–	–	0.02%	107
2026 Q1	$32.5K	Sell	162 -24	-13%	-$4.96K	0.01%	105
2025 Q4	$38.4K	Sell	186 -26	-12%	-$5.2K	0.01%	115
2025 Q3	$38K	Hold	212	–	–	0.01%	112
2025 Q2	$34.2K	Hold	212	–	–	0.01%	117
2025 Q1	$36.1K	Sell	212 -3	-1%	-$521	0.02%	110
2024 Q4	$35.7K	Sell	215 -9	-4%	-$1.54K	0.02%	119
2024 Q3	$38.5K	Sell	224 -138	-38%	-$22.8K	0.02%	114
2024 Q2	$55.7K	Sell	362 -5	-1%	-$750	0.02%	105
2024 Q1	$56.4K	Sell	367 -145	-28%	-$22.1K	0.02%	107
2023 Q4	$80.9K	Sell	512 -20	-4%	-$2.87K	0.04%	102
2023 Q3	$77.9K	Hold	532	–	–	0.04%	103
2023 Q2	$81.5K	Sell	532 -35	-6%	-$5.46K	0.04%	100
2023 Q1	$87.9K	Sell	567 -122	-18%	-$19.2K	0.05%	101
2022 Q4	$106K	Sell	689 -52	-7%	-$7.67K	0.06%	99
2022 Q3	$98K	Hold	741	–	–	0.06%	100
2022 Q2	$100K	Hold	741	–	–	0.06%	100
2022 Q1	$111K	Sell	741 -3	-0.4%	-$444	0.06%	102
2021 Q4	$120K	Sell	744 -195	-21%	-$31.5K	0.06%	103
2021 Q3	$156K	Sell	939 -135	-13%	-$23.1K	0.09%	97
2021 Q2	$185K	Sell	1,074 -33	-3%	-$5.45K	0.1%	100
2021 Q1	$178K	Sell	1,107 -19	-2%	-$3.25K	0.12%	89
2020 Q4	$189K	Sell	1,126 -7	-0.6%	-$1.14K	0.13%	87
2020 Q3	$178K	Sell	1,133 -175	-13%	-$28.6K	0.14%	86
2020 Q2	$219K	Sell	1,308 -82	-6%	-$12.9K	0.19%	81
2020 Q1	$182K	Sell	1,390 -417	-23%	-$59.4K	0.19%	81
2019 Q4	$269K	Sell	1,807 -1,449	-45%	-$199K	0.22%	77
2019 Q3	$403K	Sell	3,256 -49	-1%	-$6.52K	0.35%	67
2019 Q2	$465K	Sell	3,305 -12	-0.4%	-$1.66K	0.4%	64
2019 Q1	$500K	Sell	3,317 -280	-8%	-$40.3K	0.46%	59
2018 Q4	$447K	Buy	+3,597	New	+$492K	0.47%	57

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Eukles Asset Management's FBT Position: Q2 2026 in Review

Eukles Asset Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 162 shares worth $40.2K. The position accounts for 0.02% of the portfolio, ranked #107.

Eukles Asset Management first reported a position in FBT in Q4 2018 and has held it in 31 quarters since. The position peaked at $500K in Q1 2019. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Eukles Asset Management held 162 shares of First Trust NYSE Arca Biotechnology Index Fund worth $40.2K as of Q2 2026.
Eukles Asset Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Eukles Asset Management's portfolio in Q2 2026, its #107 holding.
Eukles Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and has held it in 31 quarters since.
Eukles Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $500K in Q1 2019.
340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.